Trenbolone Hexahydrobenzylcarbonate is a synthetic anabolic-androgenic steroid ester identified by CAS Number 23454-33-3. Chemical databases list its molecular formula as C26H34O4. The hexahydrobenzylcarbonate ester gives it a distinct chemical identity from Trenbolone Acetate and Trenbolone Enanthate.
This Nova Techsciences compound page should focus on verified chemistry, analytical documentation, regulatory clarity and responsible safety information rather than physique or performance claims.
Compound Overview
- Compound name: Trenbolone Hexahydrobenzylcarbonate
- CAS Number: 23454-33-3
- Molecular formula: C26H34O4
- Compound category: Synthetic anabolic-androgenic steroid ester
- Common presentation: Injectable formulation
- Associated Nova Techsciences range: TRENOVA-HEXA
The compound name and CAS number should remain consistent across the website, packaging, structured data, Certificates of Analysis and batch-release records. This is especially important because several trenbolone esters have similar names but different chemical identifiers and technical specifications.
Chemical Identity and Quality Documentation
Trenbolone Hexahydrobenzylcarbonate consists of trenbolone linked to a hexahydrobenzylcarbonate ester. A credible compound profile should be supported by raw-material identity testing, active-compound assay, impurity analysis, reference-standard comparison, sterility testing, particulate assessment, stability evaluation and container-closure integrity.
Every batch should carry a unique identification number connected to its manufacturing history and laboratory-release results. Claims involving purity, pharmaceutical grade, sterile quality or international compliance should only be published when current supporting evidence is available.
For audiences in the United Kingdom, Netherlands and other European markets, Nova Techsciences should clearly state the compound’s legal and marketing-authorisation status, responsible organisation, intended-use limitations and adverse-event reporting process.
Safety and Regulatory Considerations
Trenbolone compounds belong to the anabolic-androgenic steroid class. Published research associates anabolic-steroid misuse with cardiovascular, endocrine, reproductive, liver and psychological harms. Research specifically examining trenbolone users has also reported serious health concerns.
Human safety evidence for this ester remains limited. Trenbolone Hexahydrobenzylcarbonate should therefore not be presented as a general health ingredient or routine human medicine. It should not be promoted for self-medication, athletic enhancement or use by minors.
Related Nova Techsciences Compounds
Drostanolone Propionate
Drostanolone Propionate is a synthetic androgenic steroid ester identified by CAS Number 521-12-0. It is chemically distinct from trenbolone and requires separate documentation covering compound identity, sterile manufacturing, cardiovascular and hormonal risks, contraindications and regulatory status.
Testosterone Phenylpropionate
Testosterone Phenylpropionate is an esterified testosterone compound identified by CAS Number 1255-49-8. Although also associated with injectable formulations, it contains a different active hormone and has a separate chemical identity, safety profile and regulatory context.
Stanozolol ROXONOVA
Stanozolol is a synthetic anabolic-androgenic steroid identified by CAS Number 10418-03-8. The injectable presentation associated with ROXONOVA requires independent information covering formulation identity, liver and cardiovascular risks, hormonal effects, sterility and batch traceability.
Methenolone Enanthate
Methenolone Enanthate is an esterified anabolic compound identified by CAS Number 303-42-4. The primary Nova Techsciences compound record has been corrected; any remaining copy showing 303-40-4 should be reviewed across content, labels and technical documents.
Testosterone Suspension
Testosterone Suspension contains non-esterified testosterone, identified by CAS Number 58-22-0. It is chemically different from trenbolone esters and requires independent information covering formulation identity, sterile quality controls, prescription status, contraindications and professional hormonal monitoring.
Trenbolone Hexahydrobenzylcarbonate should ultimately be presented through correct CAS identification, transparent analytical records, prominent safety communication and clearly stated regulatory limitations.